Recordati is expecting to sell off its pharmaceutical chemical
operations by the end of next year or early in 2004, according to
the company's chief executive, who expects €80-€90m in proceeds for
Companies that supply instruments and consumables to the life
sciences industry have been hit hard by reined in research spending
resulting from the current adverse economic climate. However, one
chief executive believes there are...
The creditors of Australian over-the-counter medicines and vitamins
manufacturer Pan Pharmaceuticals have rejected a rescue bid for the
company at a meeting held last week. Another meeting is due to be
held later today.
Chiron's headquarters is hit by two homemade bombs, with an animal
rights group claiming responsibility. The blasts caused no
casualties and only minor damage to property, but represent an
alarming escalation in the tactics used...
French company Flamel Technologies has added another high-profile
client for its drug delivery technology spurring another leap in
its shares that have already climbed almost 800 per cent over the
last 12 months.
Australian packaging group Amcor has entered into a A$330 million
(€198m) agreement to buy Rexam's healthcare flexibles packaging
business and will also buy out Danisco and Ahlstrom's 28.1 per cent
minority stake in its...